Cargando…
Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy
Immune dysregulation is a hallmark of clinically active multiple myeloma (MM). Interactions between malignant clonal cells and immune cells within the bone marrow microenvironment are associated with the formation of a milieu favorable to tumor progression. IL-10, TGF-β and other immunoregulatory pa...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039687/ https://www.ncbi.nlm.nih.gov/pubmed/36964840 http://dx.doi.org/10.1007/s12185-023-03579-x |